The Effects of Palm Olein and Palm Kernel Oil Diets on Gut Hormones and Appetite in Healthy Adults
1 other identifier
interventional
36
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the postprandial effect of palm olein- and palm kernel oil- diets compared to PUFA-rich diet (sunflower oil in this study) on gut hormones response and appetite in healthy adults. The main questions it aims to answer are:
- Do palm olein- and palm kernel oil-diets postulate to improve satiety and lower appetite compared to PUFA rich diet (sunflower oil) in healthy adults? Researchers will compare diets prepared with palm olain or palm kernel oil to a diet prepared with sunflower oil to see the effects of these three diets on gut hormones and satiety score. Participants will:
- Attend a health screening session for subjects selection according to inclusion and exclusion criteria.
- Visit the study center three times with 2 weeks apart.
- Provide blood samples and fill up questionnaires at different time point within 4 hours.
- Receive a ad libitum meal after 4 hours intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 12, 2026
CompletedFirst Submitted
Initial submission to the registry
April 13, 2026
CompletedFirst Posted
Study publicly available on registry
April 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
April 21, 2026
April 1, 2026
6 months
April 13, 2026
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Glucose-dependent Insulinotropic Polypeptide (GIP)
GIP analysed using ELISA kits using plasma sample.
postprandial from baseline (0 min) to 4 hours
Secondary Outcomes (5)
Glucagon-like Peptide 1 (GLP-1)
Postprandial from baseline (0 min) to 4 hours
Peptide YY (PYY)
Postprandial from baseline (0 min) to 4 hours
Ghrelin
Postprandial from baseline (0 min) to 4 hours
HOMA IR
Postprandial from baseline (0 min) up to 2 hours.
Cholecytokinin, CCK
Postprandial from baseline (0 min) to 4 hours.
Study Arms (6)
P
EXPERIMENTALPO-PKO-SFO
Q
EXPERIMENTALPO-SFO-PKO
R
EXPERIMENTALPKO-PO-SFO
S
EXPERIMENTALPKO-SFO-PO
T
EXPERIMENTALSFO-PO-PKO
U
EXPERIMENTALSFO-PKO-PO
Interventions
Eligibility Criteria
You may qualify if:
- Age 20 to 45 years.
- BMI 20 to 27.5 kg/m2.
- Blood pressure with 90 to 130 mmHg for systolic and 60 to 80 mmHg for diastolic measurements.
- Fasting blood glucose of 3.9 to 5.5 mmol/L.
- Fasting total cholesterol \< 6.0 mmol/L.
- Fasting triglycerides \< 2.3 mmol/L.
- Not using any form of nicotine and alcohol.
You may not qualify if:
- Diagnosed any form of heart disease, hypertension, diabetes mellitus, and metabolic syndrome with or without medication.
- Consuming any long term prescribed medications or supplements, including hormonal contraceptive pills.
- Having moderate anaemia with haemoglobin \<110 g/l for men and \<100 g/l for women.
- Having blood clotting problem
- Having difficulty in cannulation (small, thin or hard-to-find veins)
- Women who are pregnant or lactating.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Malaysia Palm Oil Boardlead
- IMU University, Malaysiacollaborator
Study Sites (1)
Malaysian Palm Oil Board
Kajang, Selangor, 43300, Malaysia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 13, 2026
First Posted
April 21, 2026
Study Start
January 12, 2026
Primary Completion (Estimated)
July 1, 2026
Study Completion (Estimated)
August 1, 2026
Last Updated
April 21, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share